Hydrogel contact lens for sustained drug release and drug release method using hydrogel contact lens for sustained drug release
Disclosed is a sustainedly drug-releasing hydrogel contact lens which can sustainedly release an anionic medicament such as an allergy-treating agent in a mildly irritating and effective manner while achieving vision correction. Specifically disclosed is a hydrogel comprising ionic monomers composed of at least a cationic monomer and an anionic monomer, wherein the component ratio of the ionic monomers is 5 to 20 mol % inclusive relative to the total amount of monomers that constitute the gel, and the content of the anionic monomer is 15 to 25 mol % inclusive relative to the content of the cationic monomer.
1. A daily disposable hydrogel contact lens for sustained drug release of sustainedly releasing a dose of an anionic drug, wherein the amount of initial release in a time period of about 4 hours after the start of wearing the hydrogel contact lens is not more than 50% of the dose of the anionic drug contained in the hydrogel contact lens, and not less than 80% of the dose of the anionic drug contained in the hydrogel contact lens is released at least in 14 hours after the start of wearing the hydrogel contact lens; and the hydrogel contact lens comprises at least:
(a) an anionic drug,
(b) a combination of (i) and (ii) as hydrophilic monomers wherein (i) is either hydroxymethyl (meth)acrylate or 2-hydroxyethyl (meth)acrylate and (ii) is either 2-hydroxypropyl (meth)acrylate or 2,3-dihydroxypropyl (meth)acrylate, and
(c) ionic monomers including a cationic monomer and an anionic monomer, the component ratio of the ionic monomers is not less than 5 mol % and not more than 20 mol % relative to the total quantity of the monomers composed in the hydrogel, and the content ratio of the anionic monomer is 15 mol % to less than 25 mol % relative to the cationic monomer.
2. The daily disposable hydrogel contact lens for sustained drug release according to claim 1 , wherein the anionic drug is an anionic drug having at least one or more carboxyl groups and the amount of anionic drug contained in the hydrogel contact lens is 0.5 to 5.0 mg.
3. The daily disposable hydrogel contact lens for sustained drug release according to claim 1 , wherein the anionic drug is sodium cromoglycate or potassium cromoglycate.
4. The daily disposable hydrogel contact lens for sustained drug release according to claim 1 , wherein the content ratio of the anionic monomer is 15 mol % to 24.55 mol % relative to the cationic monomer.